Both anatomic (aTSA) and reverse (rTSA) total shoulder arthroplasty are the standard of care for various end-stage degenerative conditions of the glenohumeral joint. Osteoarthritis (OA) is the most common indication for aTSA while Rotator Cuff Tear Arthropathy (CTA) is the most common indication for rTSA. Worldwide, the usage of both aTSA and rTSA has increased significantly due in part, to the predictability of acceptable outcomes achieved with each prosthesis type. The aim of this study is to quantify outcomes using 5 different metrics and compare results achieved for each indication using one platform total shoulder arthroplasty system which utilizes the same humeral component and instrumentation to perform both aTSA or rTSA. 200 patients (70.9 ± 7.3 yrs) were treated by two orthopaedic surgeons using either aTSA or rTSA. 73 patients received aTSA (67.4 ± 8.0 yrs) for treatment of OA (PHF: 64 patients; YM: 9 patients) and 127 patients received a rTSA (72.9 ± 6.1 yrs) for treatment of CTA (PHF: 53 patients; YM: 74 patients). These patients were scored pre-operatively and at latest follow-up using the SST, UCLA, ASES, Constant, and SPADI metrics; active abduction, forward flexion, and external rotation were also measured. The average follow-up for all patients was 31.4 ± 9.7 months (aTSA: 32.5 ± 12.1 months; rTSA: 30.8 ± 8.0 months). A Student's two-tailed, unpaired t-test was used to identify differences in pre-operative, post-operative, and pre-to-post-operative improvements in results, where p < 0.05 denoted a significant difference.Introduction
Methods
This study provides recommendations on the position
of the implant in reverse shoulder replacement in order to minimise
scapular notching and osteophyte formation. Radiographs from 151
patients who underwent primary reverse shoulder replacement with
a single prosthesis were analysed at a mean follow-up of 28.3 months
(24 to 44) for notching, osteophytes, the position of the glenoid
baseplate, the overhang of the glenosphere, and the prosthesis scapular
neck angle (PSNA). A total of 20 patients (13.2%) had a notch (16 Grade 1 and four
Grade 2) and 47 (31.1%) had an osteophyte. In patients without either
notching or an osteophyte the baseplate was found to be positioned
lower on the glenoid, with greater overhang of the glenosphere and
a lower PSNA than those with notching and an osteophyte. Female patients
had a higher rate of notching than males (13.3% Based on these findings we make recommendations on the placement
of the implant in both male and female patients to avoid notching
and osteophyte formation. Cite this article:
